Fu An Liu
Financieel Directeur/CFO bij CONCORD MEDICAL CO., LTD.
Profiel
Fu An Liu is currently holding two positions as Chief Financial & Accounting Officer & Director at Concord Medical Co., Ltd.
and as a Member-Supervisory Board at BioFirst Corp.
In the past, he worked as Chief Financial & Accounting Officer & IR Contact at Sagittarius Life Science Corp.
from 2004 to 2011.
Mr. Liu completed his undergraduate degree at National Chung Hsing University.
Actieve functies van Fu An Liu
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOFIRST CORP | Directeur/Bestuurslid | 18-04-2014 |
| CONCORD MEDICAL CO., LTD. | Financieel Directeur/CFO | 06-08-2014 |
Eerdere bekende functies van Fu An Liu
| Bedrijven | Functie | Einde |
|---|---|---|
| SAGITTARIUS LIFE SCIENCE CORP | Financieel Directeur/CFO | - |
Opleiding van Fu An Liu
| National Chung Hsing University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SAGITTARIUS LIFE SCIENCE CORP | Health Technology |
| CONCORD MEDICAL CO., LTD. | Distribution Services |
| Bedrijven in privébezit | 1 |
|---|---|
BioFirst Corp.
 BioFirst Corp. BiotechnologyHealth Technology BioFirst Corp. engages in the research and development, manufacture and sale of medical equipment and medicines. Its products include testing equipment and reagents, vitreous filler, and Nano drug carriers. The company is the agent of Infopia's Clover AlcSelf glycosylated hemoglobin real time detection system, Infopia's GluKoPetA1c animal hemoglobin detection system, and BioPredictive's FibroTest and FibroMax liver fibrosis assessment tools. The company was founded on November 7, 2006 and is headquartered in Taipei, Taiwan. | Health Technology |
